MedPlus Health Services Ltd. topped a 15-company Q2 FY27 stock review attributed to HDFC Securities Institutional Equities, with NDTV Profit reporting a 44% implied upside to INR 880 per share.
In its Oct. 29 report, NDTV Profit put Route Mobile Ltd. next at 40% against a target of INR 610, followed by Tanla Platforms Ltd. at 36% to INR 815. The outlet said the percentages used share prices cited in its report, but did not give the prices’ observation date or a time horizon for the targets.
HDFC Securities’ research page lists an institutional report dated Oct. 29, 2026, on Cholamandalam Investment and Finance Company. The page does not include the full 15-stock table reported by NDTV Profit; its summary says Cholamandalam’s quarterly results were close to the firm’s estimates and noted growth in lending.
NDTV Profit reported five Buy ratings: Info Edge (India) Ltd., with a target of INR 1,475 per share; Piramal Pharma Ltd. and City Union Bank Ltd., each at INR 270; Tanla Platforms, at INR 815; and MedPlus, at INR 880.
The outlet also reported eight Add ratings: Cholamandalam, target INR 2,000 per share; Steel Authority of India Ltd. (SAIL), INR 200; Max Financial Services Ltd., INR 1,520; Star Health and Allied Insurance Company Ltd., INR 650; PNB Housing Finance Ltd., INR 1,220; Home First Finance Company India Ltd., INR 1,260; Birlasoft Ltd., INR 365; and Route Mobile, INR 610.
Bandhan Bank Ltd. and Bajaj Electricals Ltd. received Reduce ratings, with targets of INR 165 and INR 320 per share, respectively, NDTV Profit reported.
In its overview, NDTV Profit pointed to different forces across the companies, including loan growth, better operating performance and business expansion, alongside margin pressure, softer demand and regulatory concerns. Its summary did not link each factor to an individual rating.
